Vitro Biopharma Inc (DELISTED) (VTRO:DL)
Vitro Biopharma Debt to Equity Ratio: 8.538 for July 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2023 | 8.538 |
| April 30, 2023 |
| Date | Value |
|---|---|
| January 31, 2023 | 1.575 |
| October 31, 2022 | 0.9413 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.9413
Minimum
Oct 2022
8.538
Maximum
Jul 2023
3.685
Average
1.575
Median
Jan 2023
Debt to Equity Ratio Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.5683 |
| Asensus Surgical Inc | 0.00 |
| Senseonics Holdings Inc | 2.737 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 9.122M |
| Total Liabilities (Quarterly) | 8.723M |
| Shareholders Equity (Quarterly) | 0.3995M |
| Current Ratio | 0.8114 |